lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2

Lung cancer (LC) is a prevailing primary tumor in the lung. lncRNA non-coding RNA activated by DNA damage (NORAD) is a popular target in human cancers. This experiment is designed to probe the mechanism of lncRNA in LC progression. NORAD expression in normal lung epithelial cells and LC cells was ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Wenjun, Wang, Shengfei, Chen, Ruo, He, Yijun, Lu, Rongguo, Zheng, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520332/
https://www.ncbi.nlm.nih.gov/pubmed/36245705
http://dx.doi.org/10.1515/med-2022-0538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520332/
https://www.ncbi.nlm.nih.gov/pubmed/36245705
http://dx.doi.org/10.1515/med-2022-0538

Ejemplares similares